CORRECTION article

Front. Immunol.

Sec. Cancer Immunity and Immunotherapy

Volume 16 - 2025 | doi: 10.3389/fimmu.2025.1613095

Corrigendum: Harnessing Single-cell and Multi-omics Insights: STING Pathway-based Predictive Signature for Immunotherapy Response in Lung Adenocarcinoma

Provisionally accepted
Yang  DingYang Ding1Dingli  WangDingli Wang2Dali  YanDali Yan3Jun  FanJun Fan4Zongli  DingZongli Ding3Lei  XueLei Xue5*
  • 1Suqian People's Hospital of Nanjing Drum Tower Hospital Group, Suqian, Jiangsu Province, China
  • 2Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin, China
  • 3Xuzhou Medical University, Xuzhou, Jiangsu Province, China
  • 4Nanjing Medical University, Nanjing, Jiangsu Province, China
  • 5First Affiliated Hospital, Nanjing Medical University, Nanjing, China

The final, formatted version of the article will be published soon.

A Corrigendum on:Harnessing Single-cell and Multi-omics Insights: STING Pathway-based Predictive Signature for Immunotherapy Response in Lung Adenocarcinoma.(doi: 10.3389/fimmu.2025.1575084).In the original article, there was an error in the author list. The first author's name was incorrectly listed as "Ding Yang" instead of the correct name "Yang Ding".The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way.

Keywords: Non-small cell lung cancer, lung adenocacinoma, single-cell RNA sequencing, Prognosis signature, machine learning

Received: 16 Apr 2025; Accepted: 17 Apr 2025.

Copyright: © 2025 Ding, Wang, Yan, Fan, Ding and Xue. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Lei Xue, First Affiliated Hospital, Nanjing Medical University, Nanjing, China

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.

Research integrity at Frontiers

94% of researchers rate our articles as excellent or good

Learn more about the work of our research integrity team to safeguard the quality of each article we publish.


Find out more